Five of the seven MACs recently released proposed local coverage determinations, pertaining to peripheral nerve blocks. 

The agency has granted this designation to the Australia-based company's Comprehensive Care triage and prioritization solution for obstructive hydrocephalus. 

Details are still unclear. However, the administration—along with Pfizer and AstraZeneca, the two companies to sign on—promises the storefront will offer deeply discounted drugs directly to Americans. The deal allows the manufacturers to avoid import tariffs. 

Sudesh Ebenezer, MD, claims Hurley Medical Center retaliated against him after he expressed concerns over the incident. He is seeking unspecified damages.

The doctor was described as a kind, generous, funny and incredibly intelligent man who took joy in caring for others. 

The monthly audit is used to identify findings that may have been missed by referring providers within their network, along with initiating communication of radiologists' recommendations.

Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value. 

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.